<description>&lt;p&gt;Interview with Michael X. Repka, MD, MBA, author of Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial. Hosted by Neil Bressler, MD.&lt;br /&gt; &lt;br /&gt; &lt;strong&gt;Related Content:&lt;/strong&gt;&lt;/p&gt; &lt;ul&gt; &lt;li&gt;&lt;a class="related-article" href= "https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2023.2855?utm_source=podcast_platforms&amp;utm_medium=referral&amp;utm_campaign=related_article_links" target="_blank" rel="noopener"&gt;Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control&lt;/a&gt;&lt;/li&gt; &lt;/ul&gt;</description>

JAMA Ophthalmology Author Interviews

JAMA Network

Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control

JUL 13, 202313 MIN
JAMA Ophthalmology Author Interviews

Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control

JUL 13, 202313 MIN

Description

Interview with Michael X. Repka, MD, MBA, author of Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial. Hosted by Neil Bressler, MD. Related Content: